YDR269C is a hypothetical protein in S. cerevisiae with limited functional annotation. Its gene is located on chromosome IV, and orthologs are observed in other fungal species. While direct functional studies of YDR269C are sparse, yeast antibodies like this are pivotal for:
Gene Deletion Studies: Validating knockout strains in CRISPR/Cas9-modified yeast .
Protein Localization: Mapping subcellular distribution via immunofluorescence.
Interaction Networks: Co-immunoprecipitation (Co-IP) to identify binding partners.
Antibody validation follows rigorous pipelines to ensure specificity:
CRISPR/Cas9 Knockout (KO) Controls: Parental vs. KO yeast strains are compared via immunoblot to confirm antibody specificity .
Immunoblot Screening: Detects target protein in lysates (e.g., HEK-293, U2OS cells for cross-validation).
Functional Assays: Immunoprecipitation efficiency and immunofluorescence localization .
For YDR269C, validation data are not publicly disclosed, but standard protocols recommend using PaxDb proteomic databases to identify high-expression cell lines for initial testing .
Strengths:
High specificity for yeast proteins.
Compatibility with multiple experimental workflows (e.g., immunoblot, IP).
Limitations:
Limited peer-reviewed studies directly using YDR269C Antibody.
No published data on cross-reactivity with orthologs in other species.
Advancements in antibody engineering, such as computational redesign (e.g., GUIDE platform ) and structure-guided AI optimization , could enhance the utility of YDR269C Antibody. These methods improve binding affinity and cross-reactivity, addressing challenges in yeast proteomics.
STRING: 4932.YDR269C
YDR269C is a putative uncharacterized protein found in Saccharomyces cerevisiae (Baker's yeast). According to molecular data, it is predicted to be a multi-pass membrane protein, though this designation requires further validation. The protein has a molecular weight of approximately 11,506 Da. Research interest in YDR269C stems from efforts to functionally characterize the yeast proteome, particularly membrane-associated proteins that may have roles in cellular processes. Notably, the gene annotation carries a cautionary note as it overlaps with CCC2 gene and may represent a dubious gene prediction .
YDR269C antibodies are immunological reagents generated against the recombinant Saccharomyces cerevisiae YDR269C protein. The most common form is polyclonal IgG antibodies raised in rabbits, which recognize multiple epitopes of the target protein. These antibodies are typically supplied in liquid format with stabilizing agents (often 50% glycerol, 0.01M PBS at pH 7.4, and preservatives like 0.03% Proclin 300). The antibody preparation process typically involves antigen-affinity purification to enhance specificity while maintaining recognition of the native protein structure .
YDR269C antibodies require careful handling to preserve their binding capacity and specificity. Upon receipt, these antibodies should be stored at -20°C or -80°C to prevent protein degradation and maintain epitope recognition capabilities. Repeated freeze-thaw cycles should be avoided as they can lead to antibody denaturation and reduced performance. If small volumes become entrapped in the vial cap during shipment, a brief centrifugation is recommended to recover the material. When working with the antibody, aliquoting is advisable to minimize freeze-thaw cycles. For short-term use (1-2 weeks), storage at 4°C is acceptable, but long-term storage should be at -20°C or lower .
YDR269C antibody has been validated for specific research applications, primarily:
Western Blot (WB): Suitable for detecting denatured YDR269C protein in cell or tissue lysates.
Enzyme-Linked Immunosorbent Assay (ELISA): Effective for quantitative detection of YDR269C in solution.
When designing experiments, researchers should consider that each application requires specific optimization protocols. For Western blot applications, validation of antibody specificity through appropriate controls is essential, as is determination of optimal antibody dilution. ELISA applications similarly require optimization of coating conditions, blocking reagents, and antibody concentrations .
When performing Western blot analysis with YDR269C antibody, several methodological factors require attention:
| Parameter | Recommended Conditions | Considerations |
|---|---|---|
| Sample Preparation | Denaturing conditions with SDS | Complete denaturation is crucial for membrane proteins |
| Protein Loading | 10-30 μg total protein per lane | Adjust based on expression level |
| Blocking Solution | 5% non-fat milk or BSA in TBST | Optimize to reduce background |
| Primary Antibody Dilution | Start with 1:1000 | Titrate as needed for optimal signal-to-noise ratio |
| Incubation | Overnight at 4°C | Longer incubation may improve detection of low-abundance targets |
| Detection Method | HRP-conjugated secondary antibody | ECL or fluorescent detection systems both compatible |
Additionally, inclusion of positive and negative controls is essential to validate specificity. For membrane proteins like YDR269C, sample preparation methods that effectively solubilize membrane fractions are critical for accurate detection .
For ELISA applications with YDR269C antibody, protocol optimization should address:
Coating conditions: Standard coating buffers (carbonate/bicarbonate, pH 9.6) at 2-10 μg/mL of capture antibody, incubated overnight at 4°C.
Blocking: 1-5% BSA or non-fat milk in PBS, incubated for 1-2 hours at room temperature.
Sample preparation: Proper extraction method for membrane proteins is crucial, potentially requiring mild detergents.
Antibody dilution: Initial testing at 1:500-1:2000, with serial dilutions to determine optimal concentration.
Detection system: Compatible with HRP, AP, or biotin-streptavidin systems.
Researchers should systematically optimize each parameter, testing variations in a controlled manner while maintaining all other conditions constant to identify optimal protocol conditions .
Several technical challenges may arise when working with YDR269C antibody:
| Issue | Possible Causes | Solutions |
|---|---|---|
| Weak or No Signal | Insufficient protein, degraded antibody, improper detection | Increase protein loading, verify antibody viability, optimize detection reagents |
| High Background | Inadequate blocking, excessive antibody, non-specific binding | Optimize blocking conditions, titrate antibody, increase washing stringency |
| Multiple Bands | Cross-reactivity, protein degradation, post-translational modifications | Validate with knockout controls, add protease inhibitors, analyze band patterns |
| Inconsistent Results | Variable sample preparation, antibody degradation | Standardize protocols, aliquot antibody, use consistent reagent lots |
For membrane proteins like YDR269C, particular attention should be paid to extraction methods, as inadequate solubilization can lead to inconsistent results .
Validating antibody specificity is crucial for reliable research outcomes. For YDR269C antibody, consider these validation approaches:
Genetic controls: Use S. cerevisiae strains with YDR269C deletion or overexpression to confirm signal specificity.
Peptide competition assay: Pre-incubate antibody with excess purified YDR269C protein or immunizing peptide to block specific binding.
Orthogonal detection: Compare results with alternative detection methods (e.g., mass spectrometry).
Cross-reactivity testing: Test antibody against closely related proteins or in non-target species.
Multiple antibody verification: Use antibodies targeting different epitopes of YDR269C to confirm consistent detection.
Documenting validation results thoroughly enhances research reproducibility and reliability .
Implementing robust quality control measures ensures experimental reliability:
Antibody lot testing: Verify each new lot against previous lots using standardized samples.
Positive and negative controls: Include known YDR269C-expressing samples and YDR269C-negative samples in each experiment.
Standard curves: For quantitative applications, develop standard curves using recombinant YDR269C protein.
Dilution linearity: Confirm signal proportionality across a range of antibody and sample dilutions.
Reproducibility assessment: Perform technical and biological replicates to ensure consistent results.
Maintaining detailed records of lot numbers, experimental conditions, and quality control outcomes facilitates troubleshooting and ensures experimental reproducibility .
As YDR269C is predicted to be a membrane-associated protein, subcellular localization studies can provide valuable insights into its function. Methodological approaches include:
Immunofluorescence microscopy: Fix yeast cells with formaldehyde or other appropriate fixatives, permeabilize with detergents suitable for membrane proteins, and incubate with YDR269C antibody followed by fluorescently-labeled secondary antibody.
Subcellular fractionation: Separate cellular components (membrane, cytosol, organelles) through differential centrifugation, then analyze fractions by Western blot using YDR269C antibody.
Co-localization studies: Combine YDR269C antibody with markers for specific organelles or membrane domains to determine precise localization.
For membrane proteins, optimization of fixation and permeabilization conditions is particularly critical to maintain antigen accessibility while preserving membrane structure .
Understanding YDR269C's interaction partners can provide insights into its biological function. Several immunological approaches are applicable:
Co-immunoprecipitation (Co-IP): Use YDR269C antibody to precipitate the protein along with its interaction partners, followed by mass spectrometry or Western blot analysis of the precipitate.
Proximity labeling: Combine YDR269C antibody with proximity labeling techniques (BioID, APEX) to identify proteins in close spatial proximity.
Crosslinking-based methods: Apply chemical crosslinkers to stabilize transient interactions before immunoprecipitation with YDR269C antibody.
For membrane proteins like YDR269C, specialized Co-IP protocols using mild detergents that maintain membrane protein complexes are recommended. Additionally, controls addressing non-specific binding to the antibody or beads are essential .
YDR269C antibody can serve as a valuable tool in comparative proteomic studies across yeast strains, growth conditions, or stress responses:
Quantitative Western blot: Compare YDR269C expression levels across experimental conditions, normalizing to appropriate loading controls.
Immunoaffinity purification: Enrich for YDR269C from different conditions prior to proteomic analysis to identify condition-specific post-translational modifications or interaction partners.
Multiple strain analysis: Compare YDR269C expression and localization across laboratory and wild yeast strains to understand evolutionary conservation of function.
When designing such studies, researchers should consider potential cross-reactivity with homologous proteins in different yeast species and optimize protocols accordingly. Using antibody search engines and repositories can help identify the most suitable antibody for cross-species comparisons .
Combining YDR269C antibody-based approaches with genetic methodologies provides comprehensive insights:
Validating genetic modifications: Use YDR269C antibody to confirm successful gene deletion, mutation, or tagging at the protein level.
Structure-function studies: Correlate antibody-detected expression levels or localization patterns with phenotypic outcomes of specific mutations.
Regulatory network analysis: Combine chromatin immunoprecipitation of transcription factors with YDR269C antibody detection to connect transcriptional control with protein expression.
This integrated approach bridges genotype and phenotype, providing mechanistic understanding of YDR269C function and regulation. When designing such studies, coordinate epitope accessibility with genetic modification strategies to ensure antibody recognition is maintained .
When seeking validated YDR269C antibodies or validation data, researchers should consider:
Repository specificity: Some repositories specialize in certain applications (e.g., imaging) or organisms (e.g., human proteins), which may limit relevance for yeast protein research.
Validation data requirements: Assess whether repositories require specific validation data types (functional verification, specificity testing, application testing).
Data format and accessibility: Consider how validation data is presented and whether raw data is available for independent evaluation.
Community contribution: Repositories that allow researcher feedback may provide valuable real-world performance information beyond vendor claims.
Using multiple search engines can increase the likelihood of finding well-validated antibodies suitable for specific research applications .
Understanding the relative advantages of antibody-based detection versus alternative approaches informs method selection:
| Method | Advantages | Limitations | Complementarity with YDR269C Antibody |
|---|---|---|---|
| Mass Spectrometry | Unbiased detection, PTM identification | Limited sensitivity for low-abundance proteins | Can validate antibody specificity |
| Epitope Tagging | Highly specific detection | Requires genetic modification, may affect function | Validates antibody detection in tagged vs. untagged strains |
| Fluorescent Protein Fusion | Live imaging capability | Requires genetic modification, potential interference | Provides orthogonal localization confirmation |
| RNA-based Methods | Transcriptome-wide coverage | Measures mRNA not protein | Correlates transcription with antibody-detected protein levels |